Skip to main content
. 2020 Feb 20;69(6):939–950. doi: 10.1007/s00262-020-02501-2

Table 2.

PK parameters of IBI101 after Multiple Intravenous Injections at 2.5 mg/kg (mean ± SD, n = 6)

Parameters Units Study day
Day 1 Day 22
Cmax µg/mL 51.23 ± 12.19 86.88 ± 19.72
Tmax h 1.72 ± 3.17 1.72 ± 3.17
AUC0–∞ h × µg/mL 7912.74 ± 3297.42 21,048.42 ± 10,074.99
t1/2 h 140.81 ± 28.50 178.92 ± 117.23
Cl mL/h/kg 0.37 ± 0.16 0.40 ± 0.72
MRTlast h 67.42 ± 3.10 262.91 ± 124.94

Values are mean ± SD

Cmax maximum drug concentration observed in serum, AUC0–∞ area under the concentration–time curve from time zero to the last measurable concentration, t1/2 effective half-time, which was calculated by terminal phase data harvested, MRTlast mean reaction time from time zero to the last measurable

concentration